Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA has opened the reporting season for Israeli companies by publishing its fourth quarter and full year 2024 financial results.
In the fourth quarter the company reported…
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA has opened the reporting season for Israeli companies by publishing its fourth quarter and full year 2024 financial results.
In the fourth quarter the company reported…